Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Francesco Mazziotta"'
Autor:
Vincenza Gianfredi, Francesco Mazziotta, Giovanna Clerici, Elisa Astorri, Francesco Oliani, Martina Cappellina, Alessandro Catalini, Bernardo Maria Dell’Osso, Fabrizio Ernesto Pregliasco, Silvana Castaldi, Beatrice Benatti
Publikováno v:
European Journal of Investigation in Health, Psychology and Education, Vol 14, Iss 1, Pp 215-229 (2024)
Climate change is one of the main global challenges and influences various aspects of human health. Numerous studies have indeed demonstrated an association between extreme climate-related events and physical and mental health outcomes, but little is
Externí odkaz:
https://doaj.org/article/572532ac3fe24f2fb8b5c2aa3f60de48
Autor:
Francesco Mazziotta, Gabriele Buda, Maria Livia Del Giudice, Enrico Orciuolo, Edoardo Benedetti, Matilde Masini, Vincenzo De Tata, Sara Galimberti, Mario Petrini
Publikováno v:
Hematology Reports, Vol 14, Iss 1, Pp 19-23 (2022)
Amyloidosis is a rare disease that is often seen in conjunction with multiple myeloma (MM). Its damage varies depending on the anatomical site affected; however, it is believed that many cases of amyloidosis are misrecognized due to the fact that its
Externí odkaz:
https://doaj.org/article/159faeae7f8e4afea00f5857f68f7209
Autor:
Giovanni Corrao, Matteo Franchi, Federico Rea, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, Petra Giulia Della Valle, Michele Ercolanoni, Ida Fortino, Jose Jara, Olivia Leoni, Francesco Mazziotta, Elisabetta Pierini, Giuseppe Preziosi, Marcello Tirani, Massimo Galli, Guido Bertolaso, Giovanni Pavesi, Francesco Bortolan
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background The evolution of SARS-CoV-2 has led to the emergence of several new variants, and few data are available on the impact of vaccination on SARS-CoV-2 variants. We aimed to assess the association between natural (previous infection)
Externí odkaz:
https://doaj.org/article/c3cb4c3d828f4118b0a5acc129a8993c
Autor:
Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung-On Yau, Rupkatha Mukhopadhyay, Benjamin Dickins, Heidi Altmann, Michael Kramer, Hanna A. Knaus, Bruce R. Blazar, Vedran Radojcic, Joshua F. Zeidner, Andrea Arruda, Bofei Wang, Hussein A. Abbas, Mark D. Minden, Sarah K. Tasian, Martin Bornhäuser, Ivana Gojo, Leo Luznik
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 21 (2022)
Background Immune exhaustion and senescence are dominant dysfunctional states of effector T cells and major hurdles for the success of cancer immunotherapy. In the current study, we characterized how acute myeloid leukemia (AML) promotes the generati
Externí odkaz:
https://doaj.org/article/9b9ef0d762ff4c06a07a3be5dd99fa73
Autor:
Serena Salehzadeh, Francesca Guerrini, Umberto Pizzano, Susanna Grassi, Elena Ciabatti, Lorenzo Iovino, Gabriele Buda, Francesco Caracciolo, Edoardo Benedetti, Enrico Orciuolo, Matteo Pelosini, Giovanni Consani, Giovanni Carulli, Maria Rita Metelli, Francesca Martini, Francesco Mazziotta, Elisa Mazzantini, Pietro Rossi, Rita Tavarozzi, Federica Ricci, Mario Petrini, Sara Galimberti
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic
Externí odkaz:
https://doaj.org/article/b3ed2a20c6eb42cc835f2b6750f72efe
Autor:
Giovanni Corrao, Federico Rea, Matteo Franchi, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, Giulia Petra Della Valle, Michele Ercolanoni, Jose Jara, Giuseppe Preziosi, Manuel Maffeo, Francesco Mazziotta, Elisabetta Pierini, Francesco Lecis, Pierfrancesco Sanchirico, Francesco Vignali, Olivia Leoni, Ida Fortino, Massimo Galli, Giovanni Pavesi, Guido Bertolaso
Publikováno v:
Vaccines, Vol 10, Iss 4, p 623 (2022)
Background. Limited evidence exists on the balance between the benefits and harms of the COVID-19 vaccines. The aim of this study is to compare the benefits and safety of mRNA-based (Pfizer-BioNTech and Moderna) and adenovirus-vectored (Oxford-AstraZ
Externí odkaz:
https://doaj.org/article/54a26e55f19e4ff4847b03060c482acd
Autor:
Sara Galimberti, Elisa Genuardi, Francesco Mazziotta, Lorenzo Iovino, Fortunato Morabito, Susanna Grassi, Elena Ciabatti, Francesca Guerrini, Mario Petrini
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact
Externí odkaz:
https://doaj.org/article/8e69ab0163fe43b099563a91e74a4962
Autor:
Susanna Grassi, Sara Palumbo, Veronica Mariotti, Diego Liberati, Francesca Guerrini, Elena Ciabatti, Serena Salehzadeh, Claudia Baratè, Serena Balducci, Federica Ricci, Gabriele Buda, Lorenzo Iovino, Francesco Mazziotta, Francesco Ghio, Giacomo Ercolano, Antonello Di Paolo, Antonella Cecchettini, Chiara Baldini, Letizia Mattii, Silvia Pellegrini, Mario Petrini, Sara Galimberti
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL
Externí odkaz:
https://doaj.org/article/28ae6790330a483ea33f3ea5cbfc0329
Autor:
Sara Galimberti, Elena Ciabatti, Giacomo Ercolano, Susanna Grassi, Francesca Guerrini, Nadia Cecconi, Martina Rousseau, Giulia Cervetti, Francesco Mazziotta, Lorenzo Iovino, Franca Falzetti, Flavio Falcinelli, Alberto Bosi, Luigi Rigacci, Sofia Kovalchuk, Daniele Vallisa, Lucia Macchia, Eugenio Ciancia, Mario Petrini
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are
Externí odkaz:
https://doaj.org/article/35b73cce08bf4c5f99731c2b93b4f543
Autor:
Ivana Gojo, Jonathan S. Serody, Leo Luznik, Nathan D. Montgomery, Mark J. Levis, B. Douglas Smith, Amy E. DeZern, Gabrielle T. Prince, Jonathan A. Webster, Hendrik Van Deventer, Katarzyna Jamieson, Catherine C. Coombs, Matthew C. Foster, Hanna A. Knaus, Francesco Mazziotta, Rupkatha Mukhopadhyay, Alec D. Wilkinson, Karen P. McKinnon, Dominic Moore, Anastasia Ivanova, Benjamin G. Vincent, Joshua F. Zeidner
Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574ae48df49e97c2a4bc9c7170265627
https://doi.org/10.1158/2643-3230.22543396.v1
https://doi.org/10.1158/2643-3230.22543396.v1
